top of page

Search Results

Results found for "British Pharmacological Society"

Posts (302)

  • Pharmacologic Models

    straight to it:   Why models are vital for translating lab data into clinical forecasts The 4 types of pharmacologic Elevate your pharmacology expertise. Unlock "Pharmacologic Models" now

  • Drug Discovery Pharmacology Principles That Turn Assays Into Real Medicines

    Many pharmacology experiments produce beautifully clean assay curves. Pharmacology exists precisely to bridge that gap. Kenakin used those questions to explore how pharmacological reasoning turns experimental signals into influence discovery decisions Drug Discovery Pharmacology Principles in Action Drug discovery pharmacology Subscribers gain access to: Weekly pharmacology lectures by Dr.

  • Competitive vs Non-Competitive GPCR Antagonists: How to Interpret Pharmacology Data with Confidence

    Welcome back GPCR lovers, In pharmacology, the wrong interpretation of antagonist behavior can derail This week in Terry’s Corner , we go beyond the dose-response curves to explore the kinetic and pharmacologic edge by staying on top of the latest breakthroughs in allostery, biased signaling, and computational pharmacology Keywords: GPCR, drug discovery, pharmacology, antagonism, competitive, non-competitive, Terry's Corner excellence, drug development, pharmaceutical, scientific career Hashtags: #DrGPCR #GPCR #DrugDiscovery #Pharmacology

View All

Other Pages (215)

  • Chris Langmead | Dr. GPCR Ecosystem

    He has a degree and PhD in pharmacology from Queens' College, Cambridge and University College London , respectively, was the youngest person to be elected as a Fellow of the British Pharmacological Society in 2012, and was the recipient of the British Pharmacological Society Novartis Prize in 2017. Chris serves on the editorial boards of the British Journal of Pharmacology, ACS Chemical Neuroscience , ACS Pharmacology & Translational Science and Frontiers in Pharmacology.

  • Robert Laprairie | Dr. GPCR Ecosystem

    The focus of his research is the molecular pharmacology of cannabinoids and cannabinoid receptors. He was the 2018 and 2021 recipient of the Young Investigator of the Year Awards from the British Pharmacological Society and International Cannabinoid Research Society (ICRS), respectively. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses

  • Dr. Graham Ladds | Dr. GPCR Ecosystem

    In 2020, he was promoted to a Readership/Professor in Receptor Pharmacology and was elected a Fellow of the British Pharmacological Society. His research group uses a combination of pharmacological investigations and mathematical modeling to industry (GSK, Takada, and Firmenich) which have recently been enhanced through him being awarded a Royal Society GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses

View All
bottom of page